Lysogene is formerly owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2015.

When did Sofinnova Partners acquire Lysogene?

Sofinnova Partners acquired Lysogene in 2015 and exited after 3 years.

Has Lysogene been sold?

Yes. Lysogene was exited in 2018.

Biotech·

France·Exited 2018·Held 3yr

Lysogene is a healthcare / biotech company, headquartered in France.

Entry

2015

Hold

3yr

Exit

2018

Est. EV

–

Investor

HQFrance

SectorHealthcare / Biotech

French clinical-stage gene therapy company targeting severe genetic central nervous system diseases in children.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Capital VIII

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings